AgomAb Therapeutics NV (AGMB)

AgomAb Therapeutics NV Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	758	-	-	-
Enterprise Value	607	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.00
Quick Ratio	13.63	19.02	12.80	2.39
Current Ratio	13.99	19.05	12.81	2.39
Return on Equity (ROE)	-	-27.26%	-10.46%	-
Return on Assets (ROA)	-	-15.90%	-14.32%	-
Return on Capital Employed (ROCE)	-34.90%	-24.30%	-19.40%	-31.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q